Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Tattoo; Pigmentation
Interventions
OTHER

Vibrancy Assessment

Additionally, important medical events that may not result in death, be life threatening, or require hospitalization may be considered SAEs when, based on appropriate medical judgment, they may jeopardize the subject and may require medical or surgical intervention to prevent one of the outcomes listed above.

Trial Locations (1)

06460

Brennal Pierre, Milford

Sponsors
All Listed Sponsors
lead

Ephemeral Solutions Inc.

INDUSTRY